Events
Healthcare Days JP Morgan Week 2026
San Francisco, USA
11th January 2026
Yann GODFRIN, Ph.D., Chief Executive Officer of Axoltis Pharma, Luca Bolliger, Chief Business Officer and Jean-Guillaume Lafay, Vice Chairman of the Supervisory Board were more than delighted to participate in the J.P. Morgan Healthcare Conference in San Francisco!
The conference offered us an excellent opportunity to engage in highly constructive discussions with pharmaceutical companies regarding our NX210c asset, exploring partnership opportunities ahead of the Phase 2 clinical trial topline results, expected in Q2 2026.
